ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentHorgenCDR-Life AG
CDR-Life AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The company develops and commercializes new medicines, particularly T-cell activated cancer medicines, and provides services in the areas of research and development, clinical trials, pharmacology, toxicology and analytics.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

CDR-Life AG

Pharmaceutical Industry
✓ Offered10
Antibody-based T-cell engagers
Antibody-based T-cell engagers for oncology and autoimmune diseases, developed with the M-gager® platform for high tumor selectivity and targeted immune-cell control.
M-gager® platform
Proprietary antibody-fragment platform for developing selective T-cell engagers, with a modular binding architecture, good drug properties and scalable manufacturing.
Oncology programs
Tumor-selective T-cell engagers against solid tumors that are difficult to treat, including CDR404, CDR505, CDR609 and CDR813 for different cancer antigens.
Autoimmunity programs
Targeted therapeutics for autoimmune diseases that address specific immune-cell populations and aim to reset the immune system to a healthy state.
CDR404
Bivalent, bispecific M-gager® against MAGE-A4-positive solid tumors, currently in a Phase 1 study evaluating safety, tolerability and first efficacy.
CDR609
Antibody-based M-gager® against LGR5-expressing solid tumors, developed as a next-generation T-cell engager for selective recruitment of T-cells.
CDR505
Tumor-selective M-gager® against KK-LC-1 on HLA-A*01, designed for common cancers and a patient population that has not yet been addressed.
CDR813
Differentiated M-gager® against PRAME with high potency and specificity to treat cancer cells without targeting normal tissue.
CDR111
T-cell engager against two B-cell targets for effective B-cell depletion, with a potential curative approach in multiple autoimmune diseases.
Partnerships and R&D collaborations
Partnerships with pharmaceutical companies, academic partners and other stakeholders, including joint development and licensing of new targets via the M-gager® platform.
Trust & reputation

ranQ Trust Score of CDR-Life AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

CDR-Life AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
CDR-Life AG scores 87.0 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.83.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.90.07%
CDR-Life AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
CDR-Life AG scores 60.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.60.04%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.60.04%
Qualifications+0.00

CDR-Life AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

November 6, 2025Media
CDR-Life strikes CHF 456 million deal with Boehringer Ingelheim
venturelab.swiss
November 5, 2025Media
CDR-Life to receive up to CHF 456 million in license agreement with Boehringer Ingelheim
startupticker.ch
September 16, 2024Media
Positive clinical progress in the biotech scene
startupticker.ch
December 14, 2023Media
CDR-Life advances into the clinical phase
startupticker.ch
May 11, 2021Media
CDR-Life moves towards clinical trials
startupticker.ch

Knowledge

No knowledge articles yet

Once CDR-Life AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

CDR-Life AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank CDR-Life AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of CDR-Life AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Tödistrasse 46
8810 Horgen

At a glance

Legal form
Corporation
UID
CHE-255.051.249
Founded
2017 · 9 years
Last commercial register change
July 8, 2026
Employees
51 to 100
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    NS
    NILT Switzerland GmbH
    Horgen
    NT
    Numab Therapeutics AG
    Horgen
    SB
    Seito Biologics AG
    Küsnacht Zh
    SA
    Sensoryx AG
    Zurich
    PA
    Philochem AG
    Otelfingen
    CA
    CHoNova AG
    Oberhasli
    MA
    Mabylon AG
    Schlieren
    FF
    Forschungsstiftung für Informationstechnologie und Gesellschaft
    Zurich